Gene · 3752
Papers2,071
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,071
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Three-dimensional scaffold-free microtissues engineered for cardiac repair. | J Mater Chem B | 2020 | 32724973 | PubTator, text mining | PubMed |
| Genetics of Atrial Fibrillation in 2020: GWAS, Genome Sequencing, Polygenic Risk, and Beyond. | Circ Res | 2020 | 32716721 | PubTator, text mining | PubMed |
| 'Resistance is futile?' - paradoxical inhibitory effects of KATP channel closure in glucagon-secreting α-cells. | J Physiol | 2020 | 32716554 | PubTator, text mining | PubMed |
| Inter-Regulation of Kv4.3 and Voltage-Gated Sodium Channels Underlies Predisposition to Cardiac and Neuronal Channelopathies. | Int J Mol Sci | 2020 | 32709127 | PubTator, text mining | PubMed |
| The oral Ca/calmodulin-dependent kinase II inhibitor RA608 improves contractile function and prevents arrhythmias in heart failure. | ESC Heart Fail | 2020 | 32691522 | PubTator, text mining | PubMed |
| Combined signaling of NF-kappaB and IL-17 contributes to Mesenchymal stem cells-mediated protection for Paraquat-induced acute lung injury. | BMC Pulm Med | 2020 | 32680482 | PubTator, text mining | PubMed |
| Inherited cardiac arrhythmias. | Nat Rev Dis Primers | 2020 | 32678103 | PubTator, text mining | PubMed |
| Electrophysiological effects of non-vitamin K antagonist oral anticoagulants on atrial repolarizing potassium channels. | Europace | 2020 | 32676673 | PubTator, text mining | PubMed |
| Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias. | Int J Mol Sci | 2020 | 32668612 | PubTator, text mining | PubMed |
| Bioinformatics-based analysis of the lncRNA-miRNA-mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma. | Biosci Rep | 2020 | 32662828 | PubTator, text mining | PubMed |
| Intellectual Disability and Potassium Channelopathies: A Systematic Review. | Front Genet | 2020 | 32655623 | PubTator, text mining | PubMed |
| The Multifaced Perspectives of Genetic Testing in Pediatric Cardiomyopathies and Channelopathies. | J Clin Med | 2020 | 32635562 | PubTator, text mining | PubMed |
Anticancer potential of new 3-nitroaryl-6-(N-methyl)piperazin-1,2,4-triazolo[3,4-a]phthalazines targeting voltage-gated K+ channel: Copper-catalyzed one-pot synthesis from 4-chloro-1-phthalazinyl-arylhydrazones. | Bioorg Chem | 2020 | 32629281 | PubTator, text mining | PubMed |
| The p.P888L SAP97 polymorphism increases the transient outward current (Ito,f) and abbreviates the action potential duration and the QT interval. | Sci Rep | 2020 | 32612162 | PubTator, text mining | PubMed |
| Neuromuscular tetanic hyperexcitability syndrome associated to a heterozygous Kv1.1 N255D mutation with normal serum magnesium levels. | Acta Myol | 2020 | 32607479 | PubTator, text mining | PubMed |
| Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration. | Breast Cancer Res | 2020 | 32605588 | PubTator, text mining | PubMed |
| Computational translation of drug effects from animal experiments to human ventricular myocytes. | Sci Rep | 2020 | 32601303 | PubTator, text mining | PubMed |
| Polyunsaturated Fatty Acids as Modulators of KV7 Channels. | Front Physiol | 2020 | 32595524 | PubTator, text mining | PubMed |
| Non-coding RNAs in neuropathic pain. | Neuronal Signal | 2020 | 32587755 | PubTator, text mining | PubMed |
| Pregnancy-induced hypertension decreases Kv1.3 potassium channel expression and function in human umbilical vein smooth muscle. | Eur J Pharmacol | 2020 | 32562800 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3752/papers?page=33